Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2003
06/03/2003US6572664 Indolizine derivatives, compositions comprising at least one coupler chosen from indolizine derivatives and at least one oxidation base, and methods for using same
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
05/2003
05/30/2003WO2003044023A1 The use of anti-histaminics for acute reduction of elevated intracranial pressure
05/30/2003WO2003044021A2 Substituted indolizine-like compounds and methods of use
05/30/2003WO2003044020A1 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof
05/30/2003WO2003044019A1 4-(oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof
05/30/2003WO2003044018A1 1h-pyrrolo[3,2-b]pyridine-3-carboxylic acid amides
05/30/2003WO2003044017A1 Beta 3 adrenergic agonists
05/30/2003WO2003044016A1 3-SUBSTITUTED OXINDOLE β3 AGONISTS
05/30/2003WO2003044015A2 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003WO2003043979A2 Pharmaceutically active compounds and methods of use thereof
05/30/2003WO2003043572A2 Methods and compositions related to irm compounds and toll-like receptor pathways
05/30/2003WO2003010141A3 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
05/30/2003WO2002070739A3 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
05/30/2003WO2002062795A3 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
05/30/2003CA2467542A1 1h-pyrrolo[3,2-b]pyridine-3-carboxylic acid amides
05/30/2003CA2466925A1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
05/30/2003CA2466072A1 Substituted indolizine-like compounds and methods of use
05/29/2003US20030100764 Thioether substituted imidazoquinolines
05/29/2003US20030100759 Selective anti-viral nucleoside chain terminators
05/29/2003US20030100751 Coupling condensation synthesis of heterocycles
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100579 Useful for treatment of diseases such as obsessive compulsive disorder, panic attacks, anxiety, sexual dysfunction, eating disorders, obesity, addictive disorders
05/29/2003US20030100578 For example, (7R,8R,9R)-2,3-Dimethyl-8-hydroxy-7-(2-methoxyethoxy)-9-phenyl-7H-8,9 -dihydro-pyrano-(2,3-c)imidazo(1,2-a)pyridine
05/29/2003US20030100576 Methods and compounds for inhibiting mrp1
05/29/2003US20030100572 Such as (4-(6-(2,6-dichlorophenyl)-8-methyl-7-oxo-4a,7,8,8a -tetrahydropyrido(2,3)pyrimidin-2-ylamino)-phenyl)-phosphono -methyl)phosphonic acid for treatment of bone disorders and cancer
05/29/2003US20030100571 Such as 2-((6-(((4-(3,4-dimethoxyphenyl)methyl)amino)-7-ethyl-7H-purin-2-yl)amino) -4,5-methyl-N-phenyl-5-thiazole-carboxamide for treatment of lymphocyte mediated diseases such as transplant rejection and graft versus host disease
05/29/2003US20030100562 Anticoagulants such as (3S,6R,8R)-bicyclo(4.4.0)-1,4-diaza-3-(3-guanidinopropyl)-4-N-(3-methyl-8 -quinolinesulfonyl)-8-methyl-2,5-decanedione, hydrochloride salt
05/29/2003US20030100561 Treatment of insulin resistance with growth hormone secretagogues
05/29/2003US20030100560 Such as 2,3-dimethoxy-dibenzo(c,h)cinnoline for treatment of cancer; fungicides
05/29/2003US20030100554 Pyrazole derivatives
05/29/2003US20030100494 Containing growth hormone secretion promoting substance for prophylaxis and therapy of diseases involving degeneration or death of nerve cells
05/28/2003EP1314726A1 Novel ester or amide derivatives
05/28/2003EP1313740A1 Prodrugs of imidazopyridine derivatives
05/28/2003EP1313739A1 Alkylated imidazopyridine derivatives
05/28/2003EP1313736A2 Condensed pyrazindione derivatives
05/28/2003EP1313735A1 Liquid crystalline 3,4:9,10-perylenetetracarboxylic acid diimides
05/28/2003EP1313734A2 Aza heterocyclic derivatives and their therapeutic use
05/28/2003EP1313733A1 Pyrazolopyridine compound and pharmaceutical use thereof
05/28/2003EP1313732A1 Oxindole derivatives
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313708A1 Quinoline antibacterial compounds and methods of use thereof
05/28/2003EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists
05/28/2003EP1313478A2 Method for treatment of migraine using pde5 inhibitors
05/28/2003EP1313473A2 Sustained release formulations for growth hormone secretagogues
05/28/2003EP1189903B1 Novel benzo[f]naphthyridine, preparation and compositions containing them
05/28/2003EP1163239B1 Modified amino-acid amides as cgrp antagonists
05/28/2003EP1155001A4 Isoquinoline derivatives and isoquinoline combinatorial libraries
05/28/2003EP0888352B1 Fused imidazole derivatives as multidrug resistance modulators
05/28/2003EP0788360B1 Boronic ester and acid compounds, synthesis and uses
05/28/2003EP0686162B1 Improved method for the refolding of proteins
05/28/2003CN1420890A Tricyclic imidazopyridines
05/28/2003CN1420889A Pharmaceutically active isoindoline derivs.
05/28/2003CN1420886A (5R)-(methylamino)-5,6-dihydro-4H-imidazo ÒÇö4,5,1-ijÒÇòquinoline-2 (1H)-thione
05/28/2003CN1420882A Substd. oxoazaheterocyclyl compounds
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1109679C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/28/2003CN1109544C Beta-alkoxyacrylates against malaria
05/27/2003US6569895 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
05/27/2003US6569887 (−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake
05/27/2003US6569869 Annulated azole derivatives useful as microbicidal agents
05/27/2003US6569544 Electroluminescent device
05/22/2003WO2003042213A1 Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
05/22/2003WO2003042212A1 Improved process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one
05/22/2003WO2003042211A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/22/2003WO2003042207A1 Thiazolyl substituted triazoles as alk5 inhibitors
05/22/2003WO2003042185A1 Xanthine oxidase inhibitors
05/22/2003WO2003042178A1 Novel piperidine derivatives as modulators of chemokine receptors
05/22/2003WO2003042176A1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation
05/22/2003WO2003042175A1 Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
05/22/2003WO2003006670A3 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
05/22/2003WO2002100350A3 Dopamine receptor ligands and therapeutic methods based thereon
05/22/2003WO2002085886A3 Chiral, broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
05/22/2003WO2002044183A3 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
05/22/2003US20030096998 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections
05/22/2003US20030096843 Preventives/remedies for kidney diseases
05/22/2003US20030096838 Novel triazolo-pyridines anti-inflammatory compounds
05/22/2003US20030096836 2-Aroylimidazole compounds for treating cancer
05/22/2003US20030096835 Amido ether substituted imidazoquinolines
05/22/2003US20030096833 Use in inhibiting inflammation, cell death and in treating shock and reperfusion injuries
05/22/2003US20030096829 1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors
05/22/2003US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition
05/22/2003US20030096826 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family
05/22/2003US20030096825 Antiviral activity; treatment of HIV and AIDS
05/22/2003US20030096821 Resolution of trans-7-(hydroxy-methyl)octahydro-2H-pyrido-1,2a)pyrazine
05/22/2003US20030096819 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
05/22/2003US20030096813 Compositions useful as inhibitors of GSK-3
05/22/2003US20030096812 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
05/22/2003US20030096806 For use as pesicides, herbicides; crop protection
05/22/2003US20030096804 Bicyclic inhibitors of factor Xa
05/22/2003US20030096803 Such as 1-(6-(4-Fluoro-phenoxy)-pyridin-3-yl)-1,7,9-triaza-spiro(4.5)decane-2,6,8,10-tetraone for treatment of inflammation and cancer
05/22/2003US20030096705 Antagonists of MCP-1 function and methods of use thereof
05/22/2003CA2467267A1 Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1312363A1 Methods of treatment and kits comprising a growth hormone secretagogue
05/21/2003EP1311625A2 Functionalized perylene tetracarboxylic acid diimides
05/21/2003EP1311511A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity
05/21/2003EP1311509A1 Process for the preparation of imidazopyridines
05/21/2003EP1311508A2 Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments
05/21/2003EP1311507A1 Fused pyrazole derivatives being protein kinase inhibitors
1 ... 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 ... 646